ThermoGenesis Holdings, Inc. (THMO)
OTCMKTS
· Delayed Price · Currency is USD
0.210
0.00 (0.00%)
Sep 25, 2024, 4:00 PM EDT
ThermoGenesis Holdings Revenue
ThermoGenesis Holdings had revenue of $2.74M in the quarter ending March 31, 2024, with 6.42% growth. This brings the company's revenue in the last twelve months to $9.61M, down -7.53% year-over-year. In the year 2023, ThermoGenesis Holdings had annual revenue of $9.45M, down -9.90%.
Revenue (ttm)
9.61M
Revenue Growth
-7.53%
P/S Ratio
0.07
Revenue / Employee
384.40K
Employees
25
Market Cap
3.32M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.45M | -1.04M | -9.90% |
Dec 31, 2022 | 10.48M | 1.19M | 12.79% |
Dec 31, 2021 | 9.29M | -450.00K | -4.62% |
Dec 31, 2020 | 9.74M | -3.30M | -25.32% |
Dec 31, 2019 | 13.05M | 3.38M | 34.89% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 920.97M |
Medexus Pharmaceuticals Inc. | 108.78M |